Trademark Overview
On Sunday, March 10, 2024, a trademark application was filed for STAYGEN with the United States Patent and Trademark Office. The USPTO has given the STAYGEN trademark a serial number of 98442407. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, September 25, 2024. The STAYGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Dietary supplements for animals; Dietary supplements for humans; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Gene therapy research; Pharmaceutical research and development; RNA interference technology research; Development of gene-based medicines; Development of pharmaceutical preparations and medicines; Laboratory research in the field of gene expression; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy